Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.52 |
| ▸ | TSHR | P16473 | 4/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.50 |
| ▸ | ESR1 | P03372 | 2/20 | 0.50 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.50 |
| ▸ | RELA | Q04206 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | GFER | P55789 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.42 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9838144 | 1.00 | TDP1 (0.57) | TDP1CYP3A4ALDH1A1TSHRHSD17B10 | |
| SCHEMBL16965834 | 0.98 | TDP1 (0.55) | TDP1CYP3A4ALDH1A1TSHRHSD17B10 | |
| SCHEMBL31325538 | 0.98 | TDP1 (0.55) | TDP1CYP3A4ALDH1A1TSHRHSD17B10 | |
| Hydrochloric Acid SCHEMBL9007656 | 0.98 | TDP1 (0.55) | TDP1CYP3A4ALDH1A1TSHRHSD17B10 | |
| SCHEMBL16965836 | 0.98 | TDP1 (0.55) | TDP1CYP3A4ALDH1A1TSHRHSD17B10 | |
| Iodide SCHEMBL29884191 | 0.98 | TDP1 (0.55) | TDP1CYP3A4ALDH1A1TSHRHSD17B10 | |
| Formaldehyde SCHEMBL16965491 | 0.92 | TDP1 (0.48) | TDP1CYP3A4ALDH1A1TSHRHSD17B10 | |
| Formaldehyde SCHEMBL16965832 | 0.92 | TDP1 (0.48) | TDP1CYP3A4ALDH1A1TSHRHSD17B10 | |
| SCHEMBL735682 | 0.90 | ALDH1A1 (0.65) | TDP1CYP3A4ALDH1A1TSHRHSD17B10 | |
| SCHEMBL15657282 | 0.90 | ALDH1A1 (0.65) | TDP1CYP3A4ALDH1A1TSHRHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 822 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026103385-A1 | INTEGRATED PREPARATION METHOD FOR IRON-BASED PHOSPHATE MATERIAL FOR POSITIVE ELECTRODE OF SECONDARY BATTERY | 深圳珈钠能源科技有限公司 | 2026-05-21 | — | — | WO | claimed |
| US-20250361258-A1 | PROCESSES FOR MAKING PRMT5 INHIBITORS | PRELUDE THERAPEUTICS INC (US) | 2025-11-27 | — | — | US | claimed |
| EP-4321501-B1 | METHOD FOR SYNTHESIZING DIMETHYL 3-(3-OXO-2-PENTYL)CYCLOPENTYLMALONATE AND CATALYST | ZHEJIANG XINHUA CHEMICAL CO LTD (CN) | 2025-10-01 | — | — | EP | claimed |
| CN-120035598-A | Method for preparing PRMT5 inhibitor | 普莱鲁德疗法股份有限公司 | 2025-05-23 | — | — | CN | claimed |
| WO-2025106936-A1 | POLY(METH)ACRYLIMIDE MATERIALS WITH ENHANCED THERMOMECHANICAL PROPERTIES | GENCORES, INC. (US) | 2025-05-22 | — | — | WO | claimed |
| EP-4540261-A1 | PROCESSES FOR MAKING PRMT5 INHIBITORS | Prelude Therapeutics Incorporated (US) | 2025-04-23 | — | — | EP | claimed |
| WO-2025068962-A1 | CATALYST COMPOSITION FOR OLIGOMERIZATION AND A PROCESS FOR ITS PREPARATION | RELIANCE INDUSTRIES LIMITED (IN) | 2025-04-03 | — | — | WO | claimed |
| CN-119503752-A | Integrated preparation method of secondary battery anode iron-based phosphate material | 深圳珈钠能源科技有限公司 | 2025-02-25 | — | — | CN | claimed |
| US-12209107-B2 | Process for preparing high puritiy allopregnanolone and intermediates thereof | CRYSTAL PHARMA, S.A.U. (ES) | 2025-01-28 | — | — | US | claimed |
| US-20240409490-A1 | SYNTHETIC METHOD AND CATALYST OF 3-(3-OXO-2-PENTYL)CYCLOPENTYL DIMETHYL MALONATE | Ningxia Xinhua Chemical Co., Ltd. (CN) | 2024-12-12 | — | — | US | claimed |
| WO-2007137260-A2 | PREPARATION OF POLYMER CONJUGATES OF VLA-4 ANTAGONISTS VIA A MITSUNOBU' S REACTION | ELAN PHARMACEUTICALS, INC. (US) | 2007-11-29 | — | — | WO | claimed |
| EP-1598053-B1 | Use of a composition containing at least one phosphine as majority reducing agent to remove the artificial colour of keratinic fibres | OREAL (FR) | 2006-12-20 | — | — | EP | claimed |
| EP-1021709-A4 | ELECTROPHORESIS SEPARATION METHODS | MACQUARIE RES LTD (AU) | 2006-01-25 | — | — | EP | claimed |
| EP-1598053-A1 | Use of a composition containing at least one phosphine as majority reducing agent to remove the artificial colour of keratinic fibres | L'OREAL (FR) | 2005-11-23 | — | — | EP | claimed |
| US-20050251928-A1 | Method for stripping artificial color from keratin fibers | L'OREAL (FR) | 2005-11-17 | — | — | US | claimed |
| US-20040108209-A1 | Electrophoresis separation methods | MACQUARIE RESEARCH LTD. | 2004-06-10 | — | — | US | claimed |
| EP-1021709-A1 | ELECTROPHORESIS SEPARATION METHODS | Macquarie Research Ltd. (AU) | 2000-07-26 | — | — | EP | claimed |
| WO-1998025135-A1 | ELECTROPHORESIS SEPARATION METHODS | MACQUARIE RESEARCH LTD. (AU) | 1998-06-11 | — | — | WO | claimed |
| EP-0496393-B1 | Alkylation of azaglycine derivatives | HOECHST AG (DE) | 1995-01-25 | — | — | EP | claimed |
| US-5326875-A | Alkylation of azaglycine derivatives | HOECHST AKTIENGESELLSCHAFT (DE) | 1994-07-05 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240409490-A1 | SYNTHETIC METHOD AND CATALYST OF 3-(3-OXO-2-PENTYL)CYCLOPENTYL DIMETHYL MALONATE | MVD, FDPS, PPIP5K2 | TDP1 4587/4885CYP3A4 639/4885ALDH1A1 3188/4885 |
| US-20250361258-A1 | PROCESSES FOR MAKING PRMT5 INHIBITORS | PRMT1, PRMT5, PRMT6 | TDP1 498/4885CYP3A4 455/4885ALDH1A1 1309/4885 |
| US-20050251928-A1 | Method for stripping artificial color from keratin fibers | KRT18, DSG1, JUP | TDP1 3996/4885CYP3A4 4442/4885ALDH1A1 4512/4885 |
| US-12209107-B2 | Process for preparing high puritiy allopregnanolone and intermediates thereof | CYP21A2, CYP17A1, CYP11B1 | TDP1 4026/4885CYP3A4 62/4885ALDH1A1 561/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.